Deutsche Bank analyst Omotayo Okusanya downgraded Healthpeak Properties (DOC) to Hold from Buy with a price target of $18, down from $28. The firm sees a challenging outlook for the biotechnology life sciences real estate space. Channel checks indicate continued sluggish demand and potentially more bankruptcies of small biotech companies, the analyst tells investors in a research note. Deutsche believes Healthpeak is facing a difficult back half of 2025 for occupancy.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DOC:
- Healthpeak Properties downgraded to Hold from Buy at Deutsche Bank
- Ex-Dividend Date Nearing for These 10 Stocks – Week of August 18, 2025
- Healthpeak Properties Completes $500 Million Senior Notes Offering
- Healthpeak Properties Announces $500M Senior Notes Offering
- Healthpeak Properties Updates Tax Considerations in SEC Filing